Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FT-011 by Certa Therapeutics for Systemic Sclerosis (Scleroderma): Likelihood of Approval
FT-011 is under clinical development by Certa Therapeutics and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData,...